|
|
|
THE EXTRACELLULAR SIGNAL-REGULATED RAF/MEK/ERK SIGNALING PATHWAY (PW:0000102)
DescriptionThe
extracellular signal regulated MAP kinase pathway (Raf/Mek/Erk) couples signals
reverberating from activated cell surface receptors via their downstream
effectors, to many cytoplasmic and nuclear targets. Raf/Mek/Erk displays the
characteristic three-tier core cascade MAPK architecture. The downstream and
effector MAPK tier (here Erk represented by Mapk1 and 3) is activated by
phosphorylation of threonine and tyrosine residues within the conserved TEY
motif in the activation loop by dual specificity kinases of the middle MAP2K
tier (here Mek represented by Map2k1 and 2), in turn activated by the upstream
MAP3K tier (here Raf). While the Raf proteins are the main MAP3Ks, other MAP3Ks
can activate this and other MAPK signaling (e.g. Map3k1/Mekk1 also acting as a
MAP3K for JNK pathway). Downstream of growth factors activated receptor
tyrosine kinases, various effectors and adapters lead to activation of small
monomeric G proteins of the Ras family. Activated Ras bind to and recruit the
Raf proteins to the plasma membrane where through a series of phosphorylation,
dephosphorylation and other events they get activated. Of the several members
of Ras, Kras appears to be a more potent inducer of the Raf/Mek/Erk cascade.
The three mammalian Raf proteins - Araf, Braf and Raf1/Craf are
serine/threonine kinases whose primary targets are the Map2k1/Mek1 and
Map2k2/Mek2 members of the MAP2K tier. Mapk1/Erk2 and Mapk3/Erk1 are
serine/threonine kinases whose targets include transcription factors, cytoplasmic
proteins as well as other kinases referred to as MAPKAPK. The latter can be considered a fourth tier which further transmits
the signal through the many targets it controls. Phosphorylated MAPKs are the targets of many phosphatases such as
Pp2a - a serine/threonine phosphatase complex, Ptprr (known as PTP-SL) - a
tyrosine phosphatase, or by members of the dual specificity phosphatases of the
MKP/Dusp family, eg. Dusp6. Pp2a dephosphorylates and downregulates the
activity of Mek while dephosphorylation of Raf helps rescue it from an inactive
state leading to its activation. Pp2a activity is stimulated by kinases and
appears to be a target of p38 MAPK raising the possibility that Erk signaling
is negatively regulated by p38 MAPK pathway. Raf is negatively regulated by
phosphorylation within the regulatory domain, eg. Akt, or through the
interaction with Pebp1/Rkip that inhibits its kinase activity. Scaffold
proteins, such as Ksr1 and KSR2 (human, help organize the core modules and shape their activity. Ksr1 and KSR2 form ternary complexes with Raf and Mek and display kinase activity towards Mek (not shown). The scaffolding and catalytic attributes promote and/
or facilitate Raf activity towards Mek.
The MAPKs can also provide feedback regulatory loops to the upstream components
of the pathway. Raf/Mek/Erk pathway regulates processes such as proliferation,
differentiation. Deregulation of the pathway either through mutations in the
core or upstream components (eg B-Raf, Ras) or other pathways that regulate it
(eg PI3K/Akt) has been implicated in human cancer. To see the ontology report for annotations, GViewer and
download, click here
[click to see related GO term - GO:0070371,
KEGG map - map04010
and entries at Reactome - REACT_962.4;
REACT_1482.4] ...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
the extracellular signal-regulated Raf/Mek/Erk signaling pathway
|
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
|
ISS |
X |
12,556,904 |
12,568,583 |
RGD:5686410 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
ISS |
4 |
67,117,759 |
67,243,058 |
RGD:5686410 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
IMP |
4 |
67,117,759 |
67,243,058 |
RGD:1580106 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
IMP |
4 |
67,117,759 |
67,243,058 |
RGD:1626216 |
RGD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
|
ISS |
7 |
36,893,264 |
36,897,494 |
RGD:2293881 |
RGD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
|
ISS |
1 |
201,385,705 |
201,388,987 |
RGD:5686410 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
IDA |
4 |
182,869,242 |
182,895,106 |
RGD:628557 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:5686410 |
RGD |
| G |
Ksr1 |
kinase suppressor of ras 1 |
|
|
ISS |
10 |
65,186,444 |
65,322,155 |
RGD:2293880 |
RGD |
| G |
Ksr1 |
kinase suppressor of ras 1 |
|
|
ISS |
10 |
65,186,444 |
65,322,155 |
RGD:5686410 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
TAS |
8 |
68,379,074 |
68,451,554 |
RGD:70317 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
IMP |
8 |
68,379,074 |
68,451,554 |
RGD:1626216 |
RGD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
|
NAS |
7 |
10,074,654 |
10,094,003 |
RGD:729046 |
RGD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
|
IMP |
7 |
10,074,654 |
10,094,003 |
RGD:1626216 |
RGD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
|
ISS |
2 |
43,062,252 |
43,126,058 |
RGD:2293879 |
RGD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
|
ISS |
2 |
43,062,252 |
43,126,058 |
RGD:1357969 |
RGD |
| G |
Map3k2 |
mitogen activated protein kinase kinase kinase 2 |
|
|
NAS |
18 |
24,606,219 |
24,672,732 |
RGD:724475 |
RGD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
|
IDA |
11 |
85,968,732 |
86,030,387 |
RGD:628468 |
RGD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
|
IMP |
11 |
85,968,732 |
86,030,387 |
RGD:1626216 |
RGD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
|
IDA |
1 |
185,935,044 |
185,941,245 |
RGD:628468 |
RGD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
|
IMP |
1 |
185,935,044 |
185,941,245 |
RGD:1626216 |
RGD |
| G |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
|
|
ISS |
5 |
136,100,236 |
136,141,344 |
RGD:2315047 |
RGD |
| G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
|
|
ISS |
7 |
10,550,040 |
10,561,100 |
RGD:2315047 |
RGD |
| G |
Nras |
neuroblastoma ras oncogene |
|
|
ISS |
2 |
198,292,650 |
198,300,286 |
RGD:5686410 |
RGD |
| G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
|
IMP |
12 |
40,491,393 |
40,495,593 |
RGD:2302807 |
RGD |
| G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
|
TAS |
12 |
40,491,393 |
40,495,593 |
RGD:2293882 |
RGD |
| G |
Prkcd |
protein kinase C, delta |
|
|
IMP |
16 |
5,954,218 |
5,975,743 |
RGD:1642529 |
RGD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
IMP |
15 |
45,589,222 |
45,717,866 |
RGD:1642630 |
RGD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
|
ISS |
4 |
151,752,583 |
151,775,609 |
RGD:5686410 |
RGD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
|
IMP |
4 |
151,752,583 |
151,775,609 |
RGD:1580106 |
RGD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
|
TAS |
4 |
151,752,583 |
151,775,609 |
RGD:70317 |
RGD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
|
IMP |
4 |
151,752,583 |
151,775,609 |
RGD:1626216 |
RGD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
|
ISS |
5 |
151,274,666 |
151,288,007 |
RGD:2315047 |
RGD |
| G |
Rps6ka2 |
ribosomal protein S6 kinase polypeptide 2 |
|
|
ISS |
1 |
47,424,106 |
47,560,373 |
RGD:2315047 |
RGD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
|
ISS |
X |
56,722,878 |
56,825,444 |
RGD:2315047 |
RGD |
| G |
Rps6ka4 |
ribosomal protein S6 kinase, polypeptide 4 |
|
|
ISS |
1 |
209,505,327 |
209,516,071 |
RGD:2315047 |
RGD |
| G |
Rps6ka5 |
ribosomal protein S6 kinase, polypeptide 5 |
|
|
ISS |
6 |
124,820,623 |
124,999,790 |
RGD:2315047 |
RGD |
| G |
Rps6ka6 |
ribosomal protein S6 kinase polypeptide 6 |
|
|
ISS |
X |
99,798,274 |
99,901,585 |
RGD:2315047 |
RGD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
|
IMP |
2 |
211,851,304 |
211,855,511 |
RGD:1304283 |
RGD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
|
IEP |
2 |
181,616,581 |
181,628,144 |
RGD:1643182 |
RGD |
| G |
Smad1 |
SMAD family member 1 |
|
|
IMP |
19 |
30,348,886 |
30,409,345 |
RGD:1643230 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
|
|
|
RGD:1581337 |
RGD |
| G |
Tsc2 |
tuberous sclerosis 2 |
|
|
ISS |
10 |
13,848,210 |
13,883,189 |
RGD:1580097 |
RGD |
altered extracellular signal-regulated Raf/Mek/Erk signaling pathway
|
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
ISS |
4 |
67,117,759 |
67,243,058 |
RGD:2293882 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
ISS |
4 |
67,117,759 |
67,243,058 |
RGD:2298531 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
ISS |
4 |
67,117,759 |
67,243,058 |
RGD:5133242 |
RGD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
|
ISS |
4 |
67,117,759 |
67,243,058 |
RGD:5133243 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
TAS |
4 |
182,869,242 |
182,895,106 |
RGD:2306732 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:4143515 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:5490965 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:5490966 |
RGD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
|
ISS |
4 |
182,869,242 |
182,895,106 |
RGD:5133242 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
ISS |
8 |
68,379,074 |
68,451,554 |
RGD:5133243 |
RGD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
|
ISS |
8 |
68,379,074 |
68,451,554 |
RGD:5133242 |
RGD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
|
ISS |
4 |
151,752,583 |
151,775,609 |
RGD:2293882 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the the extracellular signal-regulated Raf/Mek/Erk signaling pathway
|
|
|
|
|
| Braf | Carcinoma, Non-Small-Cell Lung , Cardiofaciocutaneous syndrome , Colorectal Neoplasms , Germinoma , LEOPARD SYNDROME 3 , Lung Neoplasms , Melanoma , NOONAN SYNDROME 7 , Ovarian Neoplasms , Prostatic Neoplasms | | Dusp6 | Brain Ischemia , Seizures | | Hras | Carcinoma, Transitional Cell , Costello Syndrome , Diabetes Mellitus, Experimental , Diabetic Retinopathy , Mammary Neoplasms, Experimental , Mouth Neoplasms , Nevus, Epidermal , Seminoma , Thyroid cancer, follicular , Urinary Bladder Neoplasms , Uterine Cervical Neoplasms | | Kras | Abnormalities, Multiple , Astrocytoma , Breast Neoplasms , Carcinoma, Endometrioid , Carcinoma, Non-Small-Cell Lung , Carcinoma, Renal Cell , Carcinoma, Transitional Cell , Cardiofaciocutaneous syndrome , Cardiomyopathy, Dilated , Colorectal Neoplasms , Endometrial Hyperplasia , Endometrial Neoplasms , Hypertension , Intellectual Disability , Kidney Failure, Chronic , Leukemia, Myeloid, Acute , Lung Neoplasms , Multiple Myeloma , Noonan Syndrome , Noonan syndrome 3 , Ovarian Neoplasms , Pancreatic Neoplasms , Prostatic Intraepithelial Neoplasia , Prostatic Neoplasms , Sarcoma, Experimental , Seminoma , Stomach Neoplasms , Urinary Bladder Neoplasms , Uterine Cervical Neoplasms | |
| Map2k1 | Brain Ischemia , Breast Neoplasms , Carcinoma, Non-Small-Cell Lung , Carcinoma, Renal Cell , Cardiofaciocutaneous syndrome , Cardiovascular Abnormalities , Liver Neoplasms, Experimental , Ovarian Neoplasms , Prostatic Neoplasms | | Map2k2 | Breast Neoplasms , Cardiofaciocutaneous syndrome , Ovarian Neoplasms | | Map3k1 | Breast Neoplasms | |
| Mapk1 | Brain Ischemia , Breast Neoplasms , Cardiomegaly , Coronary Restenosis , Myocardial Infarction , Myocardial Reperfusion Injury | |
|
|
| Nras | Arthritis, Experimental , Carcinoma, Transitional Cell , Colorectal Neoplasms , Lymphoproliferative Disorders , Mouth Neoplasms , Nevus, Epidermal , Noonan Syndrome 6 , Prostatic Neoplasms , Rectal Neoplasms , Sarcoma, Experimental , Thyroid cancer, follicular , Uterine Cervical Neoplasms | | Pebp1 | Alzheimer Disease , Heart Defects, Congenital , Lymphatic Metastasis , Myocardial Infarction , Neoplasm Metastasis , Ovarian Neoplasms , Prostatic Neoplasms | | Prkcd | Brain Ischemia , Burns , Cardiomegaly , Cardiomyopathy, Restrictive , Diabetes Mellitus, Experimental , Fatty Liver , Hyperinsulinism , Hypertension , Hypertension, Portal , Hypertrophy, Left Ventricular , Hypertrophy, Right Ventricular , Insulin Resistance , Muscular Diseases , Myocardial Ischemia , Myocardial Reperfusion Injury , Obesity , Stroke | | Ptk2b | Anti-Glomerular Basement Membrane Disease , Brain Ischemia , Breast Neoplasms , Glomerulonephritis , Hypertension , Hypertrophy, Left Ventricular , Insulin Resistance , Osteoporosis, Postmenopausal , Prostatic Neoplasms , Reperfusion Injury , Status Epilepticus | | Raf1 | Ischemia , LEOPARD Syndrome , LEOPARD syndrome, 2 , Noonan Syndrome 5 | |
|
| Rps6ka3 | Coffin-Lowry Syndrome , Intellectual Disability | |
|
|
| S1pr1 | Cardiomegaly , Reperfusion Injury | | Shc1 | Alzheimer Disease , Carcinoma, Hepatocellular , Fatty Liver , Hepatitis, Chronic , Hyperglycemia , Hyperlipidemias , Hypertrophy, Left Ventricular , Insulin Resistance | | Smad1 | Charcot-Marie-Tooth disease, Type 2D , Cranial Nerve Injuries , Diabetes Mellitus, Experimental , Glomerulonephritis , Granulosa Cell Tumor , Hypertension, Pulmonary , Infertility, Male , Liver Cirrhosis, Experimental , Myocardial Reperfusion Injury , Nephrotic Syndrome , NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA , Testicular Neoplasms | | Spp1 | Acute Kidney Injury , Albuminuria , Aneurysm , Angina Pectoris , Anti-Glomerular Basement Membrane Disease , Arthritis, Rheumatoid , Biliary Atresia , Calcinosis , Carcinoma, Endometrioid , Carcinoma, Hepatocellular , Carcinoma, Non-Small-Cell Lung , Cardiomegaly , Coronary Artery Disease , Coronary Restenosis , Diabetes Mellitus, Experimental , Diabetic Nephropathies , Encephalomyelitis , Fibrosis , Foreign-Body Reaction , Glioma , Glomerulonephritis , Glomerulosclerosis , Hepatitis , Hepatitis C, Chronic , Hypertension, Renovascular , Inflammation , Kidney Calculi , Laryngeal Neoplasms , Liver Cirrhosis, Experimental , Malaria , Melanoma , Multiple Myeloma , Multiple Sclerosis , Myocardial Infarction , Myocardial Reperfusion Injury , Myocarditis , Neoplasm Metastasis , Neoplasms, Cystic, Mucinous, and Serous , Neovascularization, Pathologic , Neuritis, Autoimmune, Experimental , Ovarian Neoplasms , Pancreatic Neoplasms , Polycystic Kidney, Autosomal Dominant , Prostatic Neoplasms , Radiculopathy , Renal Insufficiency , Scrapie , Seizures , Spinal Cord Injuries , Stomach Neoplasms , Thyroid Neoplasms , Trauma, Nervous System , Tuberculosis , Urinary Bladder Neoplasms , Urinary Calculi | | Tsc2 | Alzheimer Disease , Lymphangioleiomyomatosis , Tuberous Sclerosis | |
| Malaria | Spp1 | | Noonan Syndrome | Kras | | Pancreatic Neoplasms | Kras , Spp1 | | Abnormalities, Multiple | Kras | | Ischemia | Raf1 | | Calcinosis | Spp1 | | Intellectual Disability | Kras , Rps6ka3 | | Inflammation | Spp1 | | Heart Defects, Congenital | Pebp1 | | Astrocytoma | Kras | | Carcinoma, Renal Cell | Kras , Map2k1 | | Renal Insufficiency | Spp1 | | Obesity | Prkcd | | Seizures | Dusp6 , Spp1 | | Aneurysm | Spp1 | | Cardiovascular Abnormalities | Map2k1 | | Granulosa Cell Tumor | Smad1 | | Cardiomegaly | S1pr1 , Prkcd , Mapk1 , Spp1 | | Cardiofaciocutaneous syndrome | Kras , Map2k2 , Map2k1 , Braf | | Stomach Neoplasms | Kras , Spp1 | | Muscular Diseases | Prkcd | | Cardiomyopathy, Dilated | Kras | | Hypertension, Pulmonary | Smad1 | | Lung Neoplasms | Kras , Braf | | Fatty Liver | Prkcd , Shc1 | | Ovarian Neoplasms | Kras , Map2k2 , Pebp1 , Map2k1 , Braf , Spp1 | | Nephrotic Syndrome | Smad1 | | Polycystic Kidney, Autosomal Dominant | Spp1 | | Melanoma | Braf , Spp1 | | Acute Kidney Injury | Spp1 | | Breast Neoplasms | Kras , Map2k2 , Map2k1 , Mapk1 , Map3k1 , Ptk2b | | Tuberous Sclerosis | Tsc2 | | Kidney Failure, Chronic | Kras | | Uterine Cervical Neoplasms | Hras , Kras , Nras | | Urinary Bladder Neoplasms | Hras , Kras , Spp1 | | Alzheimer Disease | Pebp1 , Shc1 , Tsc2 | | Arthritis, Rheumatoid | Spp1 | | Thyroid Neoplasms | Spp1 | | Fibrosis | Spp1 | | Colorectal Neoplasms | Kras , Braf , Nras | | Rectal Neoplasms | Nras | | Hypertension | Kras , Prkcd , Ptk2b | | LEOPARD Syndrome | Raf1 | | LEOPARD syndrome, 2 | Raf1 | | Prostatic Neoplasms | Kras , Nras , Spp1 , Pebp1 , Map2k1 , Braf , Ptk2b | | Carcinoma, Hepatocellular | Shc1 , Spp1 | | Kidney Calculi | Spp1 | | Infertility, Male | Smad1 | | Insulin Resistance | Prkcd , Ptk2b , Shc1 | | Urinary Calculi | Spp1 | | Noonan syndrome 3 | Kras | | Laryngeal Neoplasms | Spp1 | | Hypertension, Portal | Prkcd | | Hepatitis | Spp1 | | Charcot-Marie-Tooth disease, Type 2D | Smad1 | | Neovascularization, Pathologic | Spp1 | | Hyperinsulinism | Prkcd | | Biliary Atresia | Spp1 | | Glomerulonephritis | Smad1 , Ptk2b , Spp1 | | Noonan Syndrome 5 | Raf1 | | Noonan Syndrome 6 | Nras | | Lymphoproliferative Disorders | Nras | | Albuminuria | Spp1 | | Angina Pectoris | Spp1 | | Myocardial Ischemia | Prkcd | | Arthritis, Experimental | Nras | | Glioma | Spp1 | | Sarcoma, Experimental | Kras , Nras | | Burns | Prkcd | | Neoplasms, Cystic, Mucinous, and Serous | Spp1 | | Carcinoma, Non-Small-Cell Lung | Kras , Map2k1 , Braf , Spp1 | | Carcinoma, Transitional Cell | Hras , Kras , Nras | | Cardiomyopathy, Restrictive | Prkcd | | Brain Ischemia | Prkcd , Map2k1 , Mapk1 , Dusp6 , Ptk2b | | Coronary Artery Disease | Spp1 | | Neoplasms | Spp1 | | Diabetes Mellitus, Experimental | Hras , Smad1 , Prkcd , Spp1 | | Diabetic Nephropathies | Spp1 | | Diabetic Retinopathy | Hras | | Germinoma | Braf | | Encephalomyelitis | Spp1 | | Endometrial Hyperplasia | Kras | | Leukemia, Myeloid, Acute | Kras | | Foreign-Body Reaction | Spp1 | | Mouth Neoplasms | Hras , Nras | | Trauma, Nervous System | Spp1 | | Hepatitis, Chronic | Shc1 | | Hyperlipidemias | Shc1 | | Hyperglycemia | Shc1 | | Hypertension, Renovascular | Spp1 | | Multiple Myeloma | Kras , Spp1 | | Liver Cirrhosis, Experimental | Smad1 , Spp1 | | Liver Neoplasms, Experimental | Map2k1 | | Lymphatic Metastasis | Pebp1 | | Neoplasm Metastasis | Pebp1 , Spp1 | | Mammary Neoplasms, Experimental | Hras | | Multiple Sclerosis | Spp1 | | Myocardial Infarction | Spp1 , Pebp1 , Mapk1 | | Myocarditis | Spp1 | | Neuritis, Autoimmune, Experimental | Spp1 | | Radiculopathy | Spp1 | | Scrapie | Spp1 | | Spinal Cord Injuries | Spp1 | | Status Epilepticus | Ptk2b | | Testicular Neoplasms | Smad1 | | Tuberculosis | Spp1 | | Reperfusion Injury | S1pr1 , Ptk2b , Spp1 | | Myocardial Reperfusion Injury | Smad1 , Prkcd , Mapk1 , Spp1 | | Osteoporosis, Postmenopausal | Ptk2b | | Endometrial Neoplasms | Kras | | Hypertrophy, Left Ventricular | Prkcd , Ptk2b , Shc1 | | Hypertrophy, Right Ventricular | Prkcd | | Lymphangioleiomyomatosis | Tsc2 | | Seminoma | Hras , Kras | | Carcinoma, Endometrioid | Kras , Spp1 | | Prostatic Intraepithelial Neoplasia | Kras | | Hepatitis C, Chronic | Spp1 | | Anti-Glomerular Basement Membrane Disease | Ptk2b , Spp1 | | Cranial Nerve Injuries | Smad1 | | Stroke | Prkcd | | Coronary Restenosis | Spp1 , Mapk1 | | Coffin-Lowry Syndrome | Rps6ka3 | | Costello Syndrome | Hras | | NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA | Smad1 | | NOONAN SYNDROME 7 | Braf | | LEOPARD SYNDROME 3 | Braf | | Thyroid cancer, follicular | Hras , Nras | | Nevus, Epidermal | Hras , Nras | | Glomerulosclerosis | Spp1 | |
|